Jupiter Life Line Hospitals Limited (JLHL) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

CompoundingAI Research Updated July 27, 2026 3 min read

Jupiter Life Line Hospitals enters Q1 FY27 navigating a transition period as its new Dombivli facility completes its first full quarter of operations. Investors will be focused on the hospital's EBITDA burn rate relative to management's guidance and the ongoing occupancy trends at the Indore unit.

Quick Details

Results date	July 31, 2026
Quarter	Q1 FY 2026-2027
Previous quarter revenue	Rs. 371.7 Cr
Previous quarter PAT	Rs. 50.2 Cr
Previous quarter EBITDA margin	23.0%
Market cap	Rs. 10683.68 Cr
CMP	Rs. 327.0

Jupiter Life Line Hospitals Limited Q1 Results Date and Time

The board meeting is scheduled for July 31, 2026, to consider standalone and consolidated unaudited results for Q1 FY27.

An earnings conference call is scheduled for August 3, 2026, at 10:00 AM IST to discuss the Q1 FY27 results.

What to expect from Jupiter Life Line Hospitals Limited's Q1 FY27 results

Q1 FY27 marks the first full quarter of operations for the 200-bed Dombivli facility, which is expected to influence consolidated revenue growth while maintaining a near-term EBITDA drag. Management has guided for an EBITDA burn of Rs. 2–3 Cr per month for the facility during FY27, a key metric to monitor against the Rs. 9.4 Cr operational loss reported over approximately six weeks in Q4 FY26. While mature units like Thane operate near 75% capacity, the Indore hospital remains a focus with occupancy recorded at 45–50% in Q4, staying below the 60% threshold required to trigger Phase 2 expansion. Structural headwinds including higher depreciation and finance costs, alongside rupee depreciation impacting imported medical equipment costs, are expected to pressure margins throughout the quarter. The upcoming call will likely address the search for a new CFO following the resignation of Mr. Sivasis Sen effective May 31, 2026, and provide updates on construction progress for the Pune South project.

Key Things To Watch

Dombivli operational ramp-up: Tracking the first full quarter of operations for the new 200-bed unit.

Monitor actual EBITDA burn vs the guided Rs. 2–3 Cr/month range
Update on insurance empanelment and NABH accreditation status
Revenue run-rate and occupancy percentage data

Indore hospital occupancy: Evaluating progress toward the Phase 2 expansion trigger.

Indore occupancy was 45–50% in Q4 FY26
Phase 2 expansion of 111 beds is contingent on reaching ~60% occupancy

Strategic capex and expansion: Monitoring the status of long-term growth projects.

Pune South (Bibwewadi) construction progress and first-year spend target of ~Rs. 75 Cr
Thane hospital floor expansion remains delayed pending regulatory approvals
Status of Medulla Healthcare merger pending NCLT sanction

Financial governance and leverage: Key metrics following recent management changes and debt-funded growth.

Status of CFO succession following Mr. Sivasis Sen's resignation
Maintenance of self-imposed leverage ceiling of 3x EBITDA
Impact of higher depreciation and finance costs on consolidated PAT margins

Frequently Asked Questions

What was the EBITDA burn for the Dombivli hospital in the previous quarter?

The Dombivli hospital contributed an operational loss of Rs. 9.4 Cr to the Q4 FY26 EBITDA. This figure reflects approximately six weeks of operations following its mid-February 2026 launch.

What is the occupancy trigger for the Indore Phase 2 expansion?

Management has stated that the Phase 2 expansion, which includes 111 beds, will proceed once occupancy reaches approximately 60%. As of Q4 FY26, occupancy at the Indore unit was between 45% and 50%.

How does the company plan to fund its hospital expansion projects?

The company intends to fund its expansion from ~1,200 to ~2,900 beds over the next five years using a combination of internal accruals and debt. Management has committed to a self-imposed leverage ceiling of 3x EBITDA for these projects.